Killer‐cell immunoglobulin‐like receptor polymorphism is associated with COVID‐19 outcome: Results of a pilot observational study. - Niño‐Ramírez, J. E.; Alcoceba, M.; Gutiérrez‐Zufiaurre, M. N.; Marcos, M.; Gil‐Etayo, F. J.; Bartol‐Sánchez, M. R.; Eiros, R.; Chillón, M. C.; García‐Álvarez, M.; Terradillos‐Sánchez, P.; Presa, D.; Muñoz, J. L.; et al. (HLA: Immune Response Genetics, 2024)